ANGO vs IONS · rev $292.5M vs rev $226.6M
AngioDynamics Inc (ANGO) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
ANGO currently screens at market cap $378.5M. IONS currently screens at market cap $12.28B.
Not investment advice. Open the ANGO and IONS stock pages for the full models.
Not investment advice.